Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

117
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
117
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pneumothorax-II01:27

Pneumothorax-II

141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
141

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA<sub>1</sub> antagonism: exploratory analysis from a phase 2 trial of admilparant.

Respiratory research·2026
Same author

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026
Same author

Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically curated European ancestry datasets.

The European respiratory journal·2026
Same author

Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial.

American journal of respiratory and critical care medicine·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease.

American journal of respiratory and critical care medicine·2026

相关实验视频

Updated: Jun 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K

间歇性肺部疾病:一个回顾

Toby M Maher1,2

  • 1University of Southern California, Los Angeles.

JAMA
|April 22, 2024
PubMed
概括

间歇性肺部疾病 (ILD) 影响65万美国人,导致慢性呼吸不良和呼吸衰竭. 抗纤维素药物,免疫调节剂和肺移植等治疗可以改善ILD患者的生存率和生活质量.

科学领域:

  • 肺病学
  • 内部医学
  • 医学研究

背景情况:

  • 间歇性肺部疾病 (ILD) 是一组导致炎症和纤维化的肺部疾病,导致慢性呼吸不良和呼吸衰竭.
  • 美国约有65万名患者患有这种疾病,每年造成25,000-30,000人死亡.
  • 常见的ILD类型包括异常性肺纤维化 (IPF),过敏性肺炎和结缔组织疾病相关的ILD.

研究的目的:

  • 总结目前对间歇性肺病 (ILD) 的理解和治疗方法.
  • 突出ILD对患者健康和生存的影响.
  • 审查各种ILD亚型的诊断方法和治疗干预措施.

主要方法:

  • 审查有关ILD流行病学,诊断和治疗的现有文献.
  • 在ILD亚型中分析胸部计算机断层扫描的诊断准确性.
  • 评估预后指标,如强迫生命能力 (FVC) 的下降.
  • 对抗纤维菌,免疫调节,运动和氧疗法的治疗结果的评估.
  • 对肺移植结果和肺高血压终期ILD治疗的审查.

主要成果:

  • 在30%的患者中报告了咳.
  • 胸部CT显示高灵敏度 (91%) 和特异性 (71%),用于诊断像IPF这样的ILD亚型.

更多相关视频

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

868
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.2K

相关实验视频

Last Updated: Jun 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

868
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.2K
  • 在12个月内FVC下降5%使死亡风险增加一倍.
  • 抗纤维化疗法 (nintedanib,pirfenidone) 在IPF和渐进性纤维化ILD中减缓FVC下降44- 57%.
  • 免疫调节疗法可以稳定或改善CTD相关ILD的FVC.
  • 结构化的运动和氧气治疗改善了症状和生活质量.
  • 肺移植提供了较好的存活率 (5.2- 6. 7年) 与没有移植 (<2年) 终端ILD.
  • 在肺高血压的ILD患者中,吸入的特雷普罗斯提尼改善了症状.

    • 结论:

    • 需要及时诊断和治疗,以缓解慢性呼吸不良和呼吸衰竭.
    • 首线治疗包括对IPF的宁泰丹尼布/皮尔费尼和对CTD-ILD的美酸莫菲蒂尔.
    • 肺移植是晚期肺炎患者的关键选择.
    • 运动训练可以提高ILD患者的功能能力和生活质量.